OpenNashPodcasts

Person

Michael Abramoff

Michael Abramoff is a physician-scientist who discussed his work on autonomous artificial intelligence in healthcare on the NEJM AI Grand Rounds podcast. He covered his path from neuroscience to FDA authorization, how such AI could be paid for, and questions of bias and explainability.

Abramoff said he trained as a neuroscientist in Japan and began this work in 1996. He told the podcast he went to an FDA meeting in 2010 and said he wanted a computer to make a diagnosis. He also said randomized trials showed his autonomous AI raised the share of patients getting needed exams.

1 episodes · 23 quoted claims

Michael Abramoff trained as a neuroscientist in Japan, working on neural network simulations of the brain.

“ultimately became a neuroscientist in Japan working on neural network simulations of the brain.”

NEJM AI Grand Rounds · 0:03:14

Michael Abramoff came to Iowa in 2003 and won interest from the National Eye Institute at the NIH for his machine learning research.

“came to Iowa in 2003, where I was able to get NIH, National Eye Institute, excited about the type of research I was doing”

NEJM AI Grand Rounds · 0:04:48

Michael Abramoff says electronic health records slowed him down and lowered his productivity.

“electronic health records have actually slowed me down. They have lowered productivity.”

NEJM AI Grand Rounds · 0:06:04

Michael Abramoff cites Bureau of Labor Statistics data as showing declining productivity for physicians in outpatient clinics.

“When you start looking then at the data, for example, the Bureau of Labor Statistics at the Department of Labor, you can actually see that productivity has been declining for physicians, outpatient clinics.”

NEJM AI Grand Rounds · 0:06:04

When Michael Abramoff began this work in 1996, digital cameras were almost absent from medicine and were just starting in radiology.

“We're talking 1996 now. And so this was still the time that there were no digital cameras almost anywhere in medicine. It was just starting in radiology.”

NEJM AI Grand Rounds · 0:13:18

Michael Abramoff says highly experienced retina specialists disagree with each other in about 20 to 30 percent of cases.

“when I look at myself and other of my colleagues who are highly experienced retina specialists, we differ in about 20, 30 % of cases.”

NEJM AI Grand Rounds · 0:14:51

Michael Abramoff went to an FDA meeting in 2010 and told the agency he wanted a computer to make a diagnosis.

“I ultimately ended up going to FDA in 2010 at a meeting, said, I want a computer to make a diagnosis.”

NEJM AI Grand Rounds · 0:16:07

Michael Abramoff says he founded his company because he needed angel investors to fund the long path to FDA authorization, not because he set out to start a company.

“i needed angel investors and that ultimately led to finding the company so it was not like i set out to find a company”

NEJM AI Grand Rounds · 0:17:55

In 2010 an Ophthalmology Times front-page editorial by the chair of ophthalmology at Johns Hopkins, titled the Retinator, called out Michael Abramoff's AI research by name.

“there was an editorial in the most widely read ophthalmology journal in the world called Ophthalmology Times on the front page by the chair of ophthalmology at Johns Hopkins”

NEJM AI Grand Rounds · 0:00:02

Michael Abramoff and bioethicists created an ethical framework for AI that was published in the American Journal of Bioethics and used in interactions with the FDA.

“I had to learn it to create an ethical framework for AI that was published in the American Journal of Bioethics.”

NEJM AI Grand Rounds · 0:21:47

Michael Abramoff says randomized clinical trials showed his autonomous AI raised the share of patients getting needed exams and almost eliminated health disparities at clinics.

“we showed in randomized clinical trials that this autonomous AI improves, that it not only improves health equity, it literally allowed clinics to go from very low percentage of people getting the exams, they need to almost eliminating health disparities.”

NEJM AI Grand Rounds · 0:28:17

Michael Abramoff says the Federal Register contains about 30 pages in which CMS discussed its concerns and guardrails about paying for autonomous AI.

“There's literally 30 pages in the Federal Register from CMS discussing their worries and concerns, what they called guardrails”

NEJM AI Grand Rounds · 0:29:14

Michael Abramoff says John Deere showed its first autonomous tractor at CES, after healthcare had already used autonomous AI on patients.

“John Deere had the first autonomous tractor at CES last year.”

NEJM AI Grand Rounds · 0:29:48

Michael Abramoff says he appeared before the Senate Finance Committee soon after FDA authorization to discuss how to pay for autonomous AI.

“I went in front of the Senate Finance Committee and explained early on, just after FDA”

NEJM AI Grand Rounds · 0:32:16

Michael Abramoff says the relevant part of CMS can only reimburse what a physician charges because of how the Social Security Act was written.

“the part of CMS that we're talking about here is only allowed to reimburse what a physician charge. That's the way the Social Security Act was written.”

NEJM AI Grand Rounds · 0:33:18

Michael Abramoff says diabetic eye exams are worth paying for even at several hundred dollars because they avoid blindness, vision loss and costly surgeries.

“it's still worth the cost savings on the back end because of avoided blindness, visual loss, very expensive surgeries.”

NEJM AI Grand Rounds · 0:33:45

Michael Abramoff says society already pays for about 20 to 30 percent of patients to get diabetic eye exams, and he based his 55 dollar price on spreading that spending across all patients.

“there's a willingness to pay currently for about 20 % to 30 % of patients who are getting these exams.”

NEJM AI Grand Rounds · 0:34:51

Michael Abramoff says research on bias in healthcare algorithms has led the Office for Civil Rights at HHS to look into AI bias.

“which now has led to the Office of Civil Rights in HSS looking into this”

NEJM AI Grand Rounds · 0:40:48

Michael Abramoff says his company showed there was no racial bias in its AI, which the FDA examined.

“in our case, we proved that there was no racial bias in AI.”

NEJM AI Grand Rounds · 0:40:48

Michael Abramoff says his paper with the FDA divides explainability into validability, explainability and transparency.

“three very different types of explainability we call them validability explainability and transparency in the paper”

NEJM AI Grand Rounds · 0:55:36

Michael Abramoff says only about 3,000 melanomas of the eye occur in the world each year, which limits training data for AI on rare diseases.

“there's only 3,000 melanomas in the world in the eye per year”

NEJM AI Grand Rounds · 0:56:52

Michael Abramoff says ophthalmology leads in gene therapy and automated surgery, with corneal surgery almost fully automatic.

“especially in ophthalmology, which is always leading like in gene therapy, but also in automated surgery, corneal surgery, that's almost fully automatic”

NEJM AI Grand Rounds · 0:52:57

Michael Abramoff says that when he started medical school he had an Apple II computer that he built himself.

“When I started medical school, I was probably the only one in five city blocks with his own Apple II, which I built myself.”

NEJM AI Grand Rounds · 0:49:16